Article Sidebar
Views pdf: 79
STUDY OF FACTORS ASSOCIATED WITH TIME IN RANGE ACHIEVEMENTS USING CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC FOOT ULCERS
Main Article Content
Abstract
Background: Diabetic Foot Ulcer (DFU) is a leading severe complication closely linked to poor glycemic control. Time In Range (TIR), provided by Continuous Glucose Monitoring (CGM) technology, has emerged as a preferred clinical metric, helping to optimize glucose management and holding significant prognostic value for foot ulcers. Objectives: To determine the prevalence and associated factors for achieving TIR goals in type 2 diabetes mellitus patients with diabetic foot ulcers using CGM devices. Materials and methods: A descriptive cross-sectional study was conducted on 30 type 2 diabetes mellitus patients with DFU, monitored with CGM devices, and admitted to the Department of Gastroenterology, Hematology, and Endocrinology. Results: The proportion of patients achieving the glucose goal was 76,7%. Factors significantly influencing TIR in multivariate analysis included: HbA1C (OR=−8.24;p<0.05); and Total Insulin Dose (OR=0.14;p<0.05). Conclusions: The prevalence of patients achieving the TIR goal was recorded as 76.7%. Two independent factors influencing the TIR rate are HbA1C and Total Insulin Dose.
Article Details
Keywords
Continuous Glucose Monitoring, Time In Range, Diabetic Foot Ulcer.
References
2. Petersen, B. J., Linde-Zwirble, W. T., Tan, T. W., Rothenberg, G. M., Salgado, S. J., Bloom, J. D., & Armstrong, D. G. (2022), "Higher rates of all-cause mortality and resource utilization during episodes-of-care for diabetic foot ulceration", Diabetes research and clinical practice, 184, 109182.
3. Geng, X. Q., Chen, S. F., Wang, F. Y., Yang, H. J., Zhao, Y. L., Xu, Z. R., & Yang, Y. (2025), "Correlation between key indicators of continuous glucose monitoring and the risk of diabetic foot", World Journal of Diabetes, 16(3), 99277.
4. Forbes, J. M., & Fotheringham, A. K. (2017), "Vascular complications in diabetes: old messages, new thoughts", Diabetologia, 60(11), 2129–2138.
5. Hemmingsen, B., Lund, S. S., Gluud, C., Vaag, A., Almdal, T. P., & Wetterslev, J. (2013), "Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus", Cochrane Database of Systematic Reviews, (11).
6. Xie, P., Deng, B., Zhang, X., Li, Y., Du, C., Rui, S., & Deng, W. (2022), "Time in range in relation to amputation and all‐cause mortality in hospitalised patients with diabetic foot ulcers", Diabetes/Metabolism Research and Reviews, 38(2), e3498.
7. Huang, Z. X., Zhang, H. H., Huang, Y., Ye, S. L., Ma, Y. N., Xin, Y. H., Chen, X. Q., & Zhao, S. (2022), "Association of time in range with postoperative wound healing in patients with diabetic foot ulcers", International wound journal, 19(6), 1309–1318.
8. Chawla, P., Sowani, A., Parikh, R., Gupta, A., Kesavadev, J., Gokalani, R., & Chawla, M. (2025), "Association between continuous glucose monitoring derived metrics and clinical parameters in Indian people living with type 2 diabetes", Primary Care Diabetes.